Use of CTLA4Ig for induction of mixed chimerism and renal allograft tolerance in nonhuman primates

Y. Yamada, T. Ochiai, S. Boskovic, O. Nadazdin, T. Oura, D. Schoenfeld, K. Cappetta, R. N. Smith, R. B. Colvin, J. C. Madsen, D. H. Sachs, G. Benichou, A. B. Cosimi, T. Kawai

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

We have previously reported successful induction of renal allograft tolerance via a mixed chimerism approach in nonhuman primates. In those studies, we found that costimulatory blockade with anti-CD154 mAb was an effective adjunctive therapy for induction of renal allograft tolerance. However, since anti-CD154 mAb is not clinically available, we have evaluated CTLA4Ig as an alternative agent for effecting costimulation blockade in this treatment protocol. Two CTLA4Igs, abatacept and belatacept, were substituted for anti-CD154 mAb in the conditioning regimen (low dose total body irradiation, thymic irradiation, anti-thymocyte globulin and a 1-month posttransplant course of cyclosporine [CyA]). Three recipients treated with the abatacept regimen failed to develop comparable lymphoid chimerism to that achieved with anti-CD154 mAb treatment and these recipients rejected their kidney allografts early. With the belatacept regimen, four of five recipients developed chimerism and three of these achieved long-term renal allograft survival (>861, >796 and >378 days) without maintenance immunosuppression. Neither chimerism nor long-term allograft survival were achieved in two recipients treated with the belatacept regimen but with a lower, subtherapeutic dose of CyA. This study indicates that CD28/B7 blockade with belatacept can provide a clinically applicable alternative to anti-CD154 mAb for promoting chimerism and renal allograft tolerance. This study shows that belatacept promotes induction of mixed chimerism and renal allograft tolerance in nonhuman primates.

Original languageEnglish
Pages (from-to)2704-2712
Number of pages9
JournalAmerican Journal of Transplantation
Volume14
Issue number12
DOIs
Publication statusPublished - 2014 Dec 1

Keywords

  • Basic (laboratory) research/science
  • bone marrow/hematopoietic stem cell transplantation
  • kidney transplantation/nephrology
  • tolerance: chimerism
  • tolerance: costimulation blockade
  • tolerance: experimental

ASJC Scopus subject areas

  • Immunology and Allergy
  • Transplantation
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Use of CTLA4Ig for induction of mixed chimerism and renal allograft tolerance in nonhuman primates'. Together they form a unique fingerprint.

Cite this